Published in Lancet on January 01, 2000
A study of microbial colonisation of orthopaedic tourniquets. Ann R Coll Surg Engl (2009) 0.88
The effect of sterile versus non-sterile tourniquets on microbiological colonisation in lower limb surgery. Ann R Coll Surg Engl (2011) 0.78
Potential risk of cross-infection by tourniquets: a need for effective control practices in pakistan. Int J Prev Med (2014) 0.76
The safe insertion of peripheral intravenous catheters: a mixed methods descriptive study of the availability of the equipment needed. Antimicrob Resist Infect Control (2012) 0.75
Impact of a patient-centered, computer-based health information/support system. Am J Prev Med (1999) 6.60
HIV seroprevalence among women attending antenatal clinics in London. Lancet (1992) 4.46
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob Agents Chemother (1995) 2.62
Smoking cessation factors among African Americans and whites. COMMIT Research Group. Am J Public Health (1993) 2.45
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med (2001) 2.33
In-vitro detection of human rotaviruses. Lancet (1975) 2.28
The desire for multiple births in couples with infertility problems contradicts present practice patterns. Hum Reprod (1995) 2.17
Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis (1983) 2.07
Screening of pregnant women for HIV: the case against. Pract Midwife (1999) 2.05
New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines. HIV Med (2008) 1.99
Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother (2008) 1.98
Discontinuous movements of DNA and RNA in RNA polymerase accompany formation of a paused transcription complex. Cell (1995) 1.96
Asymptomatic endemic rotavirus infections in the newborn. Lancet (1978) 1.93
GreA-induced transcript cleavage in transcription complexes containing Escherichia coli RNA polymerase is controlled by multiple factors, including nascent transcript location and structure. J Biol Chem (1994) 1.92
Letter: Rotavirus infections in a maternity unit. Lancet (1975) 1.92
Characterization of vaccinia virus DNA topoisomerase I expressed in Escherichia coli. J Biol Chem (1988) 1.87
The effect of trypsin on the growth of rotavirus. J Gen Virol (1978) 1.86
The interface of sigma with core RNA polymerase is extensive, conserved, and functionally specialized. Genes Dev (1999) 1.85
Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet (2001) 1.79
Quantitative analysis of transcriptional pausing by Escherichia coli RNA polymerase: his leader pause site as paradigm. Methods Enzymol (1996) 1.78
Rotavirus infections in a maternity unit. Arch Dis Child (1976) 1.71
The persistent challenge of parastomal herniation: a review of the literature and future developments. Colorectal Dis (2013) 1.71
The use and impact of a computer-based support system for people living with AIDS and HIV infection. Proc Annu Symp Comput Appl Med Care (1994) 1.68
Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) (1982) 1.66
A hospital outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae investigated by RAPD typing and analysis of the genetics and mechanisms of resistance. J Hosp Infect (1998) 1.63
Clinical evaluation of the turkey-erythrocyte passive-haemagglutination test for hepatitis-B surface antigen. Lancet (1974) 1.59
Rubella immunity by four different techniques: results of challenge studies. J Med Virol (1980) 1.58
Increases in serum concentrations of cardiac proteins and the prediction of early postoperative cardiovascular complications in noncardiac surgery patients. Anaesthesia (2000) 1.51
Glycopeptide tolerance in Staphylococcus aureus. J Antimicrob Chemother (1998) 1.50
PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol (1995) 1.47
bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A (1995) 1.40
Cross-gendered identifications and homosexual boyhood: toward a more complex theory of gender. Am J Orthopsychiatry (1998) 1.39
Paediatric gastroenteritis in the eastern Malaysian state of Sarawak: an epidemiological and clinical study. Trans R Soc Trop Med Hyg (1988) 1.39
Veterinary nursing examinations. Vet Rec (1994) 1.38
Gender, social pressure, and smoking cessations: the Community Intervention Trial for Smoking Cessation (COMMIT) at baseline. Soc Sci Med (1997) 1.34
Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS (1999) 1.33
British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med (2008) 1.33
Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods (1992) 1.32
Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic. Lancet (1990) 1.30
Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol (1998) 1.30
Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) (1984) 1.30
Plasticized polyvinylchloride as a temporary dressing for burns. Br Med J (Clin Res Ed) (1987) 1.29
ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease. Neurogastroenterol Motil (2001) 1.24
A comparison of methods of predicting maximum oxygen uptake. Br J Sports Med (1995) 1.23
HIV screening in pregnancy: UK lags. Lancet (1994) 1.20
Practical approach to the identification of clinically relevant Enterococcus species. Diagn Microbiol Infect Dis (1999) 1.20
Cord blood and breast-milk antibodies in neonatal rotavirus infection. Br Med J (1980) 1.19
Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees. J Infect Dis (1985) 1.18
Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis. Gastroenterology (2000) 1.17
The intracellular tyrosine kinase domain of the epidermal growth factor receptor undergoes a conformational change upon autophosphorylation. J Biol Chem (1994) 1.17
Measuring quality of life of Chinese cancer patients: A validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer (2000) 1.17
Rarity of transferable beta-lactamase production by Klebsiella species. J Antimicrob Chemother (1997) 1.12
Rubella vaccines. Lancet (1979) 1.10
Insertional mutagenesis of the vaccinia virus gene encoding a type I DNA topoisomerase: evidence that the gene is essential for virus growth. Virology (1989) 1.10
Persistence of rubella antibodies after vaccination: detection after experimental challenge. Rev Infect Dis (1985) 1.08
Chronic enteric virus infection in two T-cell immunodeficient children. J Med Virol (1988) 1.07
Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. Clin Pharmacol Ther (1998) 1.07
Isolation of a new foamy retrovirus from orangutans. J Virol (1994) 1.06
Bile acid metabolism by fresh human colonic contents: a comparison of caecal versus faecal samples. Gut (2001) 1.06
PEVK extension of human soleus muscle titin revealed by immunolabeling with the anti-titin antibody 9D10. J Struct Biol (1998) 1.06
Contamination of doctors' and nurses' pens with nosocomial pathogens. Lancet (1998) 1.05
Hepatocellular carcinoma in Hong Kong: clinical study on 340 cases. Oncology (1990) 1.05
LGM (Vena Tech) vena cava filter: clinical experience in 64 patients. J Vasc Interv Radiol (1991) 1.05
Vancomycin resistance in south London. Lancet (1992) 1.05
Antiretroviral therapy for HIV-2 infected patients. J Infect (2001) 1.04
Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. J Thromb Haemost (2009) 1.04
Comparative in vitro activity of gemifloxacin. J Antimicrob Chemother (2000) 1.04
Mechanism and stability of hyperproduction of the extended-spectrum beta-lactamase SHV-5 in Klebsiella pneumoniae. J Antimicrob Chemother (1997) 1.03
Rubella serology by solid-phase radioimmunoassay: its potential for screening programmes. Clin Exp Immunol (1978) 1.03
Genotyping of B and non-B subtypes of human immunodeficiency virus type 1. J Clin Microbiol (2005) 1.03
Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction. Life Sci (2004) 1.03
Evidence for horizontal and not vertical transmission of human herpesvirus 8 in children born to human immunodeficiency virus-infected mothers. Pediatr Infect Dis J (1999) 1.02
An outbreak of multidrug-resistant Pseudomonas aeruginosa infection associated with contamination of bronchoscopes and an endoscope washer-disinfector. J Hosp Infect (2000) 1.02
A case report of bilateral absence of fallopian tubes and ovaries. Asia Oceania J Obstet Gynaecol (1987) 1.01
The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage. Am Rev Respir Dis (1989) 1.01
Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol (1995) 1.01
Smokers' baseline characteristics in the COMMIT trial. Prev Med (1995) 1.01
Transmission of RA27/3 rubella vaccine strain to products of conception. Lancet (1981) 1.01
A structure/function analysis of Escherichia coli RNA polymerase. Philos Trans R Soc Lond B Biol Sci (1996) 1.01
Amoxycillin/clavulanate resistant Escherichia coli. Lancet (1988) 1.00
Structure and function of the murine muscle-tendon junction. Anat Rec (1981) 1.00
Vergence orthoptics: validity and persistence of the training effect. Optom Vis Sci (1991) 0.99
Cancer in Hong Kong: some epidemiological observations. Natl Cancer Inst Monogr (1982) 0.99
Neonatal rotavirus infection: role of lacteal neutralising alpha1-anti-trypsin and nonimmunoglobulin antiviral activity in protection. J Med Virol (1982) 0.98
Tuberculosis and HIV seroprevalence in Lambeth, Southwark and Lewisham, an area of South London. Respir Med (2003) 0.98
Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology. J Med Virol (1993) 0.98
Renal medullary carcinoma: sonographic, computed tomography, magnetic resonance and angiographic findings. Eur J Radiol (2000) 0.98
The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring. Int J Lab Hematol (2008) 0.97
Expression of human O6-methylguanine-DNA methyltransferase in a DNA excision repair-deficient Chinese hamster ovary cell line and its response to certain alkylating agents. Cancer Res (1992) 0.97
Laminin in lung development: effects of anti-laminin antibody in murine lung morphogenesis. Dev Biol (1990) 0.97
BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease, and healthy people. Br Med J (1977) 0.96
How well do low levels of rubella antibody protect? Lancet (1981) 0.96
Multiple-antibiotic-resistant salmonella. Lancet (1998) 0.96
A study on the influence of breathing phases in intensity-modulated radiotherapy of lung tumours using four-dimensional CT. Br J Radiol (2009) 0.95
Rubella vaccination: persistence of antibodies for 10-21 years. Lancet (1988) 0.94
False positive rotazyme tests on faecal samples from babies. Lancet (1983) 0.94
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. HIV Med (2005) 0.93
Automated rubella antibody screening:a cautionary tale. J Med Microbiol (1999) 0.93